Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
---|
03/07/2007 | CN1926121A Thiazole derivatives and use thereof |
03/07/2007 | CN1925854A Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters |
03/07/2007 | CN1923823A Synthesis method of 7-bata-trityl side-chain acid as intermediate of ceftazidime pentahydrate |
03/07/2007 | CN1303074C Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
03/07/2007 | CN1303043C Process for producing biaryl compound |
03/06/2007 | US7186839 Extraction uisng aqueous solution containing metal compound |
03/06/2007 | US7186742 Benzamide inhibitors of the P2X7 receptor |
03/06/2007 | US7186735 Vasodilation; cardiovascular disorders; anticoagulants |
03/06/2007 | US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders |
03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
03/06/2007 | US7186726 Preferentially substituted calcium channel blockers |
03/06/2007 | US7186725 Anti-inflammatory compositions and methods |
03/06/2007 | US7186719 Antibacterial agents |
03/06/2007 | US7186717 Pyrrolidine derivatives as Factor Xa inhibitors |
03/06/2007 | CA2168319C 4-mercaptobenzoylguanidine derivatives |
03/06/2007 | CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
03/01/2007 | WO2007024922A1 Immunosuppressant compounds and compositions |
03/01/2007 | WO2007023882A1 Derivative having ppar agonistic activity |
03/01/2007 | WO2007002126A8 Alkyl sulfonamide derivatives |
03/01/2007 | WO2006128688B1 Process for the preparation of pramipexole |
03/01/2007 | WO2006124748A3 Multicyclic compounds and methods of their use |
03/01/2007 | US20070049635 Diamine derivatives, process for producing the same, and plant disease control agents containing the same as active ingredients |
03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
03/01/2007 | US20070049495 1-Methyl, 3-trifluoromethyl,4-(2-(4-(tert-butylpyrazol-1-yl),2-cyano,1-tert-butylcarbonyloxy)ethylene)-pyrazole; agriculture; preventing the attachment of aquatic organisms to boats, construction materials, heat excangers; coolants; water supply systems; engineering plants; reservoirs; marine/underwater |
03/01/2007 | CA2621164A1 Derivative having ppar agonistic activity |
03/01/2007 | CA2619101A1 Immunosuppressant compounds and compositions |
02/28/2007 | EP1757593A1 Therapeutic agent for nonviral hepatitis |
02/28/2007 | EP1757292A1 Method of treating ocd and tic disorders |
02/28/2007 | EP1756119A1 Collection of traceable compounds and uses thereof |
02/28/2007 | EP1756091A1 Non nucleoside reverse transcriptase inhibitors |
02/28/2007 | EP1756077A2 Multi-lamellar liquid crystal emulsion system |
02/28/2007 | EP1756076A1 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
02/28/2007 | EP1756075A1 Compound for preparing thiazole by aminomethylation |
02/28/2007 | EP1626962B1 Benzamide inhibitors of the p2x7 receptor |
02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
02/28/2007 | EP1343561B1 Serine protease inhibitors |
02/28/2007 | EP1240154B1 Serine protease inhibitors |
02/28/2007 | CN1922165A 3-(4-benzyloxyphenyl)propanoic acid derivative |
02/28/2007 | CN1922162A Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors |
02/28/2007 | CN1922160A Compounds |
02/28/2007 | CN1922159A Benzamide derivatives and their use as glucokinase activating agents |
02/28/2007 | CN1922158A Isothiourea derivatives |
02/28/2007 | CN1922144A Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
02/28/2007 | CN1922141A Novel heterocyclic compound |
02/28/2007 | CN1301980C Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
02/28/2007 | CN1301974C Muller Klaus-helmut |
02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
02/27/2007 | US7183436 Substituted 4-aminocyclohexanols |
02/27/2007 | US7183374 Diminishing concentration of metal complex from solution containing the complex by addition of an optionally fused and/or optionally substituted heterocyclic compound which is a solubility-enhancing compound that enhances solubility of complex in second solution |
02/27/2007 | US7183302 Iminothiazolidinones as inhibitors of HCV replication |
02/27/2007 | US7183300 Compounds that inhibit Hiv formation for viricides and inhibition of capsid formation |
02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
02/27/2007 | US7183286 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
02/27/2007 | US7183276 5-carbonyl or carbamido-4-(4-chlorophenyl)-2-heteroaryl oxazoles; analgesic for diabetic neuropathy |
02/27/2007 | US7183275 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis |
02/22/2007 | WO2007020400A1 Fluorination process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents |
02/22/2007 | WO2006122777A3 Use of 2,5-disubstituted thiazol-4-one derivatives in drugs |
02/22/2007 | US20070043095 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
02/22/2007 | US20070043094 Pioglitazone hydrochloride |
02/22/2007 | US20070043093 Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
02/22/2007 | US20070043087 Compounds exhibiting thrombopoietin receptor agonism |
02/22/2007 | US20070043046 Biaromatic ligand activators of PPARGAMMA receptors |
02/22/2007 | US20070042996 N-alkynyl-2-(substituted aryloxy) alkylthioamine derivatives as fungicides |
02/22/2007 | CA2618448A1 Fluorination process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents |
02/21/2007 | EP1754700A2 Synthesis of oligoketides |
02/21/2007 | EP1754492A1 Novel drug discovery target and medicine acting on the same |
02/21/2007 | EP1754477A2 Hydroxamic acid derivatives as antibacterials |
02/21/2007 | EP1753775A1 Process for preparing acyclic hcv protease inhibitors |
02/21/2007 | EP1753736A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
02/21/2007 | EP1753735A1 Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators |
02/21/2007 | EP1753734A1 Nitric oxide donors and uses thereof |
02/21/2007 | EP1753713A2 Synthesis of tetracyclines and analogues thereof |
02/21/2007 | EP1682129B1 N-thiazol-2-yl-benzamide derivatives |
02/21/2007 | EP1575900A4 N-methyl amino acids |
02/21/2007 | EP1551798B1 Novel sulphones for inhibition of gamma secretase |
02/21/2007 | EP1551797B1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
02/21/2007 | EP1501508B1 Inhibitors of histone deacetylase |
02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
02/21/2007 | CN1918134A Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cyto kine inhibitors |
02/21/2007 | CN1918132A Method of coloring with capped diazotized compound and coupling component |
02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
02/21/2007 | CN1917763A N-(2-(hydroxymethyl) phenyl)-1h-pyrazole-4-carboxamide derivatives and related compounds as microbicidal active ingredients for phyto-protection and the protection of materials |
02/21/2007 | CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
02/21/2007 | CN1301251C Compound of alpha, beta and beta, gamma unsaturation carboxylate class of possessing weeding activity |
02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
02/20/2007 | US7179912 Materials and methods to potentiate cancer treatment |
02/20/2007 | US7179896 Method of making PNA oligomers |
02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
02/20/2007 | US7179827 Such as (S)-(4-(ethylamino)-2-((4-methylpiperidin-1-yl)methyl)thiazol-5-yl)(2-(methoxymethyl)pyrrolidin-1-yl)methanone; for treatment of neurological and psychiatric disorders/diseases, cancer, and disorders mediated by protein kinase inhibition |
02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
02/20/2007 | US7179819 Benzyl -urea, -thiourea, or -guanidine derivatives that inhibit the binding of ligands to alpha 4 beta 1 integrin (VLA-4); for therapy and prophylaxis of pathologies associated with VLA-4 mediated cell adhesion, such as inflammatory and autoimmune diseases, and tumor metastasis |
02/20/2007 | US7179808 Such as 3-[[4-(4-chlorophenyl)-2-thiazolyl]methoxy]-N-propyl-benzenemethanamine; nicotinamide adenine dinucleotide oxidase hydride donor inhibitors |
02/20/2007 | CA2344574C Thyroid receptor ligands |
02/15/2007 | WO2007019346A1 Benzothiazoles and thiazolopyridines as sirtuin modulators |
02/15/2007 | WO2007019251A2 Sphingosine kinase inhibitors and methods of their use |
02/15/2007 | WO2007019210A1 Preparation of 2-amino-thiazole-5-carboxylic-acid derivatives |
02/15/2007 | WO2007018461A1 Novel benzothiazolone derivatives |
02/15/2007 | WO2007017728A2 Novel heterocyclic compounds |
02/15/2007 | WO2007017669A1 Azole and thiazole derivatives and their use |
02/15/2007 | WO2007017509A1 Compounds for the treatment of alzheimer's disease |